{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:34:15Z","timestamp":1790354055593,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2314-B-442-002-MY3"],"award-info":[{"award-number":["103-2314-B-442-002-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2314-B-442-001-MY3"],"award-info":[{"award-number":["106-2314-B-442-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4529-9","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T08:33:06Z","timestamp":1527669186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met\/Src signaling pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Wei-Chieh","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao-Lin","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"2","key":"4529_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4529_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10616-012-9511-9","volume":"65","author":"NB Vu","year":"2013","unstructured":"Vu NB, Nguyen TT, Tran LC-D, Do CD, Nguyen BH, Phan NK, Pham PV. Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties. Cytotechnology. 2013;65(4):491\u2013503.","journal-title":"Cytotechnology"},{"issue":"12","key":"4529_CR3","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-09-2824","volume":"16","author":"CA O'Brien","year":"2010","unstructured":"O'Brien CA, Kreso A, Jamieson CHM. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16(12):3113\u201320.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4529_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5(4):275\u201384.","journal-title":"Nat Rev Cancer"},{"key":"4529_CR5","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1038\/oncsis.2017.25","volume":"6","author":"SL Tung","year":"2017","unstructured":"Tung SL, Huang WC, Hsu FC, Yang ZP, Jang TH, Chang JW, Chuang CM, Lai CR, Wang LH. miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis. 2017;6:e326.","journal-title":"Oncogenesis"},{"key":"4529_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/1471-2407-14-722","volume":"14","author":"N Hashimoto","year":"2014","unstructured":"Hashimoto N, Tsunedomi R, Yoshimura K, Watanabe Y, Hazama S, Oka M. Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs. BMC Cancer. 2014;14:722.","journal-title":"BMC Cancer"},{"issue":"35","key":"4529_CR7","doi-asserted-by":"publisher","first-page":"59991","DOI":"10.18632\/oncotarget.19000","volume":"8","author":"BC K\u00f6hler","year":"2017","unstructured":"K\u00f6hler BC, Waldburger N, Schlamp K, J\u00e4ger D, Weiss KH, Schulze-Bergkamen H, Schirmacher P, Springfeld C. Liver cancers with stem\/progenitor-cell features \u2013 a rare chemotherapy-sensitive malignancy. Oncotarget. 2017;8(35):59991\u20138.","journal-title":"Oncotarget"},{"key":"4529_CR8","doi-asserted-by":"crossref","unstructured":"Lee TKW, Cheung VCH, Ng IOL. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma. Cancer Lett. 338(1):101\u20139.","DOI":"10.1016\/j.canlet.2012.05.001"},{"issue":"3","key":"4529_CR9","first-page":"235","volume":"5","author":"E Rinninella","year":"2017","unstructured":"Rinninella E, Cerrito L, Spinelli I, Cintoni M, Mele MC, Pompili M, Gasbarrini A. Chemotherapy for hepatocellular carcinoma: current evidence and future perspectives. J Clin Transl Hepatol. 2017;5(3):235\u201348.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"4529_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36\u201349.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4529_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri3806","volume":"15","author":"J Crouse","year":"2015","unstructured":"Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15(4):231\u201342.","journal-title":"Nat Rev Immunol"},{"key":"4529_CR12","doi-asserted-by":"publisher","first-page":"716315","DOI":"10.1155\/2015\/716315","volume":"2015","author":"X Meng","year":"2015","unstructured":"Meng X, Yang D, Yu R, Zhu H. EPSTI1 is involved in IL-28A-mediated inhibition of HCV infection. Mediat Inflamm. 2015;2015:716315.","journal-title":"Mediat Inflamm"},{"issue":"12","key":"4529_CR13","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1099\/vir.0.2008\/001594-0","volume":"89","author":"I Umareddy","year":"2008","unstructured":"Umareddy I, Tang KF, Vasudevan SG, Devi S, Hibberd ML, Gu F. Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol. 2008;89(12):3052\u201362.","journal-title":"J Gen Virol"},{"issue":"6","key":"4529_CR14","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","volume":"131","author":"T Marcello","year":"2006","unstructured":"Marcello T, Grakoui A, Barba\u2013Spaeth G, Machlin ES, Kotenko SV, Macdonald MR, Rice CM. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology. 2006;131(6):1887\u201398.","journal-title":"Gastroenterology"},{"issue":"7344","key":"4529_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481\u20135.","journal-title":"Nature"},{"key":"4529_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.fsi.2016.03.157","volume":"53","author":"IC McDowell","year":"2016","unstructured":"McDowell IC, Modak TH, Lane CE, Gomez-Chiarri M. Multi-species protein similarity clustering reveals novel expanded immune gene families in the eastern oyster Crassostrea virginica. Fish Shellfish Immunol. 2016;53:13\u201323.","journal-title":"Fish Shellfish Immunol"},{"issue":"3","key":"4529_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, et al. miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12(3):247\u201356.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4529_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/path.2964","volume":"226","author":"S Liu","year":"2012","unstructured":"Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-\u03baB1\u2013Snail1 pathway in melanoma. J Pathol. 2012;226(1):61\u201372.","journal-title":"J Pathol"},{"issue":"35","key":"4529_CR19","doi-asserted-by":"publisher","first-page":"29516","DOI":"10.1074\/jbc.M111.335943","volume":"287","author":"SD Selcuklu","year":"2012","unstructured":"Selcuklu SD, Donoghue MTA, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, Muniyappa MK, Kerin MJ, Enright AJ, Spillane C. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast Cancer cells. J Biol Chem. 2012;287(35):29516\u201328.","journal-title":"J Biol Chem"},{"issue":"3","key":"4529_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbrc.2012.12.097","volume":"431","author":"F Gao","year":"2013","unstructured":"Gao F, Zhao Z-L, Zhao W-T, Fan Q-R, Wang S-C, Li J, Zhang Y-Q, Shi J-W, Lin X-L, Yang S, et al. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2013;431(3):610\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4529_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1158\/1078-0432.CCR-14-1564","volume":"21","author":"Z Liu","year":"2015","unstructured":"Liu Z, Wei P, Yang Y, Cui W, Cao B, Tan C, Yu B, Bi R, Xia K, Chen W, et al. BATF2 deficiency promotes progression in human colorectal Cancer via activation of HGF\/MET signaling: a potential rationale for combining MET inhibitors with IFNs. Clin Cancer Res. 2015;21(7):1752\u201363.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4529_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1053\/gast.2002.32388","volume":"122","author":"S Radaeva","year":"2002","unstructured":"Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El\u2013Assal O, Gao B. Interferon-\u03b1 activates multiple STAT signals and down-regulates c-met in primary human hepatocytes. Gastroenterology. 2002;122(4):1020\u201334.","journal-title":"Gastroenterology"},{"key":"4529_CR23","doi-asserted-by":"publisher","first-page":"341636","DOI":"10.1155\/2013\/341636","volume":"2013","author":"NK Venepalli","year":"2013","unstructured":"Venepalli NK, Goff L. Targeting the HGF-cMET Axis in hepatocellular carcinoma. Int J Hepatol. 2013;2013:341636.","journal-title":"Int J Hepatol"},{"issue":"2","key":"4529_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.21873\/anticanres.11377","volume":"37","author":"Y-L CHEN","year":"2017","unstructured":"CHEN Y-L, HUANG W-C, YAO H-L, CHEN P-M, LIN P-Y, FENG F-Y, CHU P-Y. Down-regulation of RASA1 is associated with poor prognosis in human hepatocellular carcinoma. Anticancer Res. 2017;37(2):781\u20135.","journal-title":"Anticancer Res"},{"issue":"3","key":"4529_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1158\/0008-5472.CAN-13-1297","volume":"74","author":"W-C Huang","year":"2014","unstructured":"Huang W-C, Chan S-H, Jang T-H, Chang J-W, Ko Y-C, Yen T-C, Chiang S-L, Chiang W-F, Shieh T-Y, Liao C-T, et al. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. 2014;74(3):751\u201364.","journal-title":"Cancer Res"},{"issue":"3","key":"4529_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.yexcr.2009.11.006","volume":"316","author":"BW Booth","year":"2010","unstructured":"Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res. 2010;316(3):422\u201332.","journal-title":"Exp Cell Res"},{"key":"4529_CR27","first-page":"51046","volume":"88","author":"CR Justus","year":"2014","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014;88:51046.","journal-title":"J Vis Exp"},{"issue":"8","key":"4529_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jcp.55.8.613","volume":"55","author":"J Packeisen","year":"2002","unstructured":"Packeisen J, Buerger H, Krech R, Boecker W. Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol. 2002;55(8):613\u20135.","journal-title":"J Clin Pathol"},{"issue":"7","key":"4529_CR29","doi-asserted-by":"publisher","first-page":"e1359","DOI":"10.1038\/cddis.2014.325","volume":"5","author":"HC Yu","year":"2014","unstructured":"Yu HC, Hung MH, Chen YL, Chu PY, Wang CY, Chao TT, Liu CY, Shiau CW, Chen KF. Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A. Cell Death Dis. 2014;5(7):e1359.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4529_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/cmi.2013.64","volume":"11","author":"Y Yang","year":"2014","unstructured":"Yang Y, Hou J, Lin Z, Zhuo H, Chen D, Zhang X, Chen Y, Sun B. Attenuated listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells. Cell Mol Immunol. 2014;11(2):184\u201396.","journal-title":"Cell Mol Immunol"},{"key":"4529_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.81","volume":"6","author":"GL Chen","year":"2017","unstructured":"Chen GL, Ye T, Chen HL, Zhao ZY, Tang WQ, Wang LS, Xia JL. Xanthine dehydrogenase downregulation promotes TGF[beta] signaling and cancer stem cell-related gene expression in hepatocellular carcinoma. Oncogenesis. 2017;6:e382.","journal-title":"Oncogenesis"},{"key":"4529_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12885-015-1297-7","volume":"15","author":"T Yamada","year":"2015","unstructured":"Yamada T, Abei M, Danjoh I, Shirota R, Yamashita T, Hyodo I, Nakamura Y. Identification of a unique hepatocellular carcinoma line, li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib. BMC Cancer. 2015;15:260.","journal-title":"BMC Cancer"},{"issue":"1","key":"4529_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yexmp.2010.05.005","volume":"89","author":"S Lingala","year":"2010","unstructured":"Lingala S, Cui Y-Y, Chen X, Ruebner BH, Qian X-F, Zern MA, Wu J. Immunohistochemical staining of Cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol. 2010;89(1):27\u201335.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"4529_CR34","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.18632\/oncotarget.13852","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Shen M, Lu P, Li X, Zhu S, Yue S. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7. Oncotarget. 2017;8(1):1714\u201324.","journal-title":"Oncotarget"},{"issue":"6","key":"4529_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1586\/17474124.2015.1041509","volume":"9","author":"CHC Sukowati","year":"2015","unstructured":"Sukowati CHC, Anfuso B, Pascut D, Tiribelli C. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs. Expert Rev Gastroenterol Hepatol. 2015;9(6):723\u20135.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4529_CR36","doi-asserted-by":"crossref","unstructured":"Zhang G, Wang Z, Luo W, Jiao H, Wu J, Jiang C: Expression of potential Cancer stem cell marker ABCG2 is associated with malignant behaviors of hepatocellular carcinoma. Gastroenterol Res Pract 2013, 2013:782581.","DOI":"10.1155\/2013\/782581"},{"key":"4529_CR37","doi-asserted-by":"crossref","unstructured":"Liu Z, Dai X, Wang T, Zhang C, Zhang W, Zhang W, Zhang Q, Wu K, Liu F, Liu Y, et al. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Cancer Lett. 400:149\u201360.","DOI":"10.1016\/j.canlet.2017.04.017"},{"issue":"19","key":"4529_CR38","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells\u2014perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66(19):9339\u201344.","journal-title":"Cancer Res"},{"issue":"1","key":"4529_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-11-1","volume":"11","author":"L Cao","year":"2011","unstructured":"Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenteol. 2011;11(1):1\u201311.","journal-title":"BMC Gastroenteol"},{"issue":"23","key":"4529_CR40","doi-asserted-by":"publisher","first-page":"11234","DOI":"10.1158\/0008-5472.CAN-07-0718","volume":"67","author":"LM Hansford","year":"2007","unstructured":"Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD, et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res. 2007;67(23):11234\u201343.","journal-title":"Cancer Res"},{"issue":"4","key":"4529_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, de Oliveira AC, Santoro A, Raoul J-L, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378\u201390.","journal-title":"N Engl J Med"},{"issue":"5","key":"4529_CR42","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208\u201336.","journal-title":"Hepatology"},{"issue":"9","key":"4529_CR43","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/bjs.7669","volume":"98","author":"L Tiong","year":"2011","unstructured":"Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98(9):1210\u201324.","journal-title":"Br J Surg"},{"issue":"32","key":"4529_CR44","doi-asserted-by":"crossref","first-page":"52571","DOI":"10.18632\/oncotarget.16732","volume":"8","author":"H Li","year":"2017","unstructured":"Li H, Wang X, Fang Y, Huo Z, Lu X, Zhan X, Deng X, Peng C, Shen B. Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma. Oncotarget. 2017;8(32):52571\u201383.","journal-title":"Oncotarget"},{"issue":"15","key":"4529_CR45","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.4254\/wjh.v7.i15.1964","volume":"7","author":"C Chen","year":"2015","unstructured":"Chen C, Wang G. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy. World J Hepatol. 2015;7(15):1964\u201370.","journal-title":"World J Hepatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4529-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T16:19:40Z","timestamp":1604333980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4529-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4529-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"13 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Changhua Christian Hospital (CCH IRB No. 120504), Taiwan. The Written informed consent was provided by participants to be included in the study. The animal experiment protocols (NHRI-IACUC-104045A) were reviewed and approved by the Institutional Animal Care and Use Committee of National Health Research Institutes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"609"}}